Sclerosis, Progressive Systemic Completed Phase 4 Trials for Bosentan (DB00559)

Also known as: Systemic Sclerosis / Sclerosis, Systemic / Progressive systemic sclerosis / Scleroderma, Systemic / Scleroderma

IndicationStatusPhase
DBCOND0080156 (Sclerosis, Progressive Systemic)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01395732Bosentan in Systemic SclerosisTreatment